WHO's 41st Expert Committee on Drug Dependence (ECDD) recommended UN to reclassify cannabis and cannabis resin in 2018. UN agreed to vote in person in 2020. Cannabis and its resin were removed from the schedule IV since then. So far, Cannabis products have boomed to be the most promising biotechnological superstar. The annual sale of cannabis was up to 27 billion beyond BNT vaccine and Humira in 2021.